Reuters logo
BRIEF-Bioblast Pharma to seek strategic alternatives including partnership and merger
2017年6月5日 / 晚上8点27分 / 4 个月前

BRIEF-Bioblast Pharma to seek strategic alternatives including partnership and merger

June 5 (Reuters) - Bioblast Pharma Ltd:

* Bioblast Pharma to seek strategic alternatives including partnership and merger opportunities

* Bioblast Pharma Ltd - company receives regulatory clearance to initiate a phase 2b trial of trehalose in opmd patients

* Bioblast-At present, ‍not encumbered by license, partnership or royalty arrangements with third parties for development,commercialization of trehalose​

* Bioblast Pharma Ltd- it has engaged jsb-partners, a global life sciences advisor, to assist company in executing its “business development objectives” Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below